Article
Silencing of the tumor suppressor gene SLC5A8 is associated with BRAF mutations in classical papillary thyroid carcinomas.
The Journal of clinical endocrinology and metabolism - 1 May 2005
Porra Valérie, Ferraro-Peyret Carole, Durand Christine, Selmi-Ruby Samia, Giroud Hélène, Berger-Dutrieux Nicole, Decaussin Myriam, Peix Jean-Louis, Bournaud Claire, Orgiazzi Jacques, Borson-Chazot Françoise, Dante Robert, Rousset Bernard
Abstract excerpt
SLC5A8, proposed as a thyroid apical iodide transporter, was recently defined as a Na+-coupled transporter of short-chain fatty acid. To document the expression pattern of SLC5A8 in the thyroid, we analyzed the regulation of its expression in normal human thyrocytes in culture and in tissues with distinct functional activity. To determine whether SLC5A8 expression is altered in all thyroid carcinomas or only in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
